- Global Pharma News & Resources

Global Metabolomics Market Analysis Report to 2029 - Featuring Thermo Fisher Scientific, Agilent Technologies, Waters and Danaher Among Others -

DUBLIN--(BUSINESS WIRE)--The "Metabolomics Market Analysis by Product, by Application, by Indication, by End Use, and by Region - Global Forecast to 2029" report has been added to's offering.

The global metabolomics market size is estimated to be USD 1,986.5 Million in 2021 and is expected to witness a CAGR of 17.81% during the forecast period.

Availability of government and private funding for metabolomics research is a key driver for the growth of the global metabolomics market.

Additionally, increasing pharmaceutical and biotech R&D expenditure and growing demand for personalized medicine are some of the other drivers propelling the market growth.

Nevertheless, complexity and diversity of biological samples and high cost of tools & instruments are expected to restrain the global market growth

Companies Mentioned

  • Thermo Fisher Scientific (U.S.)
  • Agilent Technologies (U.S.)
  • Waters Corporation (U.S.)
  • Danaher Corporation (U.S.)
  • Shimadzu Corporation (Japan)
  • Bio-Rad Laboratories (U.S.)
  • Bruker Corporation (U.S.)
  • PerkinElmer Inc. (U.S.)
  • Merck KGaA (Germany)
  • GE Healthcare (U.S.)

Metabolomics Market, By Product and Service (Revenue, 2021-2029, USD Million)

Bioinformatics Tools & Services

Bioinformatics Services

  • Bioinformatics Tools & Databases


Separation Tools

  • High-Performance Liquid Chromatography
  • Gas Chromatography
  • Ultra-Performance Liquid Chromatography
  • Capillary Electrophoresis
  • Detection Tools
  • Mass Spectrometry
  • Nuclear Magnetic Resonance Spectroscopy
  • Surface-Based Mass Analysis

Metabolomics Market, By Application (Revenue, 2021-2029, USD Million)

  • Drug Discovery
  • Biomarker Discovery
  • Nutrigenomics
  • Toxicology Testing
  • Functional Genomics
  • Personalized Medicine
  • Other Applications

Metabolomics Market, By Indication (Revenue, 2021-2029, USD Million)

  • Neurological Disorders
  • Metabolic Disorders
  • Cancer
  • Cardiovascular Disorders
  • Inborn Errors of Metabolism
  • Others

Metabolomics Market, By End User (Revenue, 2021-2029, USD Million)

  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations (CROS)
  • Others

Metabolomics Market, By Region (Revenue, 2021-2029, USD Million)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 14-Dec-2022